Abstract: A method for confirming the active intake of marijuana and its active component ?9-tetrahydrocannabinol (“?9-THC”) by detecting the amount of 11-nor-?9-THC carboxylic acid (“THCA”) in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry (“GC/MS/MS”).
Type:
Grant
Filed:
October 1, 2010
Date of Patent:
July 12, 2011
Assignee:
LabOne, Inc.
Inventors:
David Day, David J. Kuntz, Michael S. Feldman
Abstract: A method for confirming the active intake of marijuana and its active component ?9-tetrahydrocannabinol (“?9-THC”) by detecting the amount of 11-nor-?9-THC carboxylic acid (“THCA”) in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry (“GC/MS/MS”).
Type:
Grant
Filed:
November 13, 2008
Date of Patent:
October 19, 2010
Assignee:
LabOne, Inc.
Inventors:
David Day, David J. Kuntz, Michael S. Feldman
Abstract: A method for confirming the active intake of marijuana and its active component ?9-tetrahydrocannabinol (“?9-THC”) by detecting the amount of 11-nor-?9-THC carboxylic acid (“THCA”) in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry (“GC/MS/MS”).
Type:
Grant
Filed:
November 3, 2004
Date of Patent:
December 16, 2008
Assignee:
LabOne, Inc.
Inventors:
David Day, David J. Kuntz, Michael S. Feldman
Abstract: The present invention is directed antibodies specific to multiple beta blockers, as well as immunogens used to produce the antibodies and immunoassay kits and methods for using the antibodies.